Metraipolis › archive › dc_e09bf256bb60

Therapeutic reprogramming of tumour-associated macrophages in pancreatic cancer using a cytotoxic CCR2-targeted nanotheranostic — Europe PMC PMID:41654815

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41654815
DOI: 10.1186/s12943-[numero omesso]-7
License (as archived): solo-consultazione
Archived: 2026-11-06T01:25:39.373Z
SHA-256 of the archived text: 4361d2221bc4c185c2bafbbcb040af6b549ff83b3cd66a909c9e44911293fcb2
Stable URL of this page: https://metraipolis.com/documento/dc_e09bf256bb60

How to cite

Therapeutic reprogramming of tumour-associated macrophages in pancreatic cancer using a cytotoxic CCR2-targeted nanotheranostic — Europe PMC PMID:41654815 — Europe PMC (en), https://europepmc.org/article/MED/41654815 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e09bf256bb60 (Metraipolis archive dc_e09bf256bb60, sha256 4361d2221bc4c185c2bafbbcb040af6b549ff83b3cd66a909c9e44911293fcb2)

BibTeX

@misc{dce09bf256bb60,
  title = {Therapeutic reprogramming of tumour-associated macrophages in pancreatic cancer using a cytotoxic CCR2-targeted nanotheranostic — Europe PMC PMID:41654815},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41654815},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e09bf256bb60; sha256 4361d2221bc4c185c2bafbbcb040af6b549ff83b3cd66a909c9e44911293fcb2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41654815. Agents can read the archived copy with the MCP tool read_document.